DYSPLASIA AND CARCINOMA IN THE BILLROTH II RESECTED STOMACH 27–35 YEARS POST‐OPERATIVELY

Abstract
In a previous endoscopic follow-up examination of patients who 22-30 yr before had undergone Billroth II resection for duodenal ulcer the prevalence of dysplasia and carcinoma of the gastric remnant was 14.8 and 0%, respectively. In this second follow-up study 5 yr later the figures had increased to 30.3 and 5.6%. It is uncertain whether these changes result from the higher number of biopsies taken at the re-examination or reflect a time-dependent rise in the morbidity. Although the observed prevalences may seem high, prophylactic endoscopic examination of such patients was not found to be indicated as the series of Billroth II resected patients under study does not show excess incidence or excess mortality of gastric carcinoma.